The Overexpression of Histone Deacetylase 1 and Its Relationship with p16 INK4a Gene Hypermethylation in Pulmonary Squamous Cell Carcinoma and Adenocarcinoma
4
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : DNA methylation and histone modification are dynamically linked in the epigenetic control of gene silencing and they play an important role in tumorigenesis. Methods : To evaluate the role of histone deacetylase 1 (HDAC1) in the development of lung cancer and the relationship between a HDAC1 overexpression and p16INK4a hypermethylation, we performed immunohistochemical staining for HDAC1 in 76 lung cancer specimens (39 squamous cell carcinomas and 37 adenocarcinomas) that had been previously evaluated for their p16INK4a methylation status by real-time quantitative polymerase chain reaction. Results : A HDAC1 overexpression (>50% of HDAC1 immunoreactive cells) was detected in 65 (85.5%) out of the 76 cases and it was more frequently seen in the squamous cell carcinomas (97.4%) than in the adenocarcinomas (73.0%) (p=0.002). The incidence of HDAC1 overexpression tended to be higher in the heavy smokers with more than 20 pack-years (p=0.067). Although there was no statistical significance, the frequency of p16INK4a hypermethylation in the cases with a HDAC1 overexpression (27.7%) tended to be higher than that in the cases without a HDAC1 overexpression (9.0%) (p=0.175). Conclusions : A HDAC1 overexpression might be involved in lung carcinogenesis, and especially in a subgroup of smoking and squamous cell carcinoma patients, and a HDAC1 overexpression may be associated with p16INK4a hypermethylation.
Abstract
Background : DNA methylation and histone modification are dynamically linked in the epigenetic control of gene silencing and they play an important role in tumorigenesis. Methods : To evaluate the role of histone deacetylase 1 (HDAC1) in the development of lung cancer and the relationship between a HDAC1 overexpression and p16INK4a hypermethylation, we performed immunohistochemical staining for HDAC1 in 76 lung cancer specimens (39 squamous cell carcinomas and 37 adenocarcinomas) that had been previously evaluated for their p16INK4a methylation status by real-time quantitative polymerase chain reaction. Results : A HDAC1 overexpression (>50% of HDAC1 immunoreactive cells) was detected in 65 (85.5%) out of the 76 cases and it was more frequently seen in the squamous cell carcinomas (97.4%) than in the adenocarcinomas (73.0%) (p=0.002). The incidence of HDAC1 overexpression tended to be higher in the heavy smokers with more than 20 pack-years (p=0.067). Although there was no statistical significance, the frequency of p16INK4a hypermethylation in the cases with a HDAC1 overexpression (27.7%) tended to be higher than that in the cases without a HDAC1 overexpression (9.0%) (p=0.175). Conclusions : A HDAC1 overexpression might be involved in lung carcinogenesis, and especially in a subgroup of smoking and squamous cell carcinoma patients, and a HDAC1 overexpression may be associated with p16INK4a hypermethylation.
참고문헌 (22)
- Egger G, "Epigenetics in human disease and prospects for epigenetic therapy", Nature, 429, pp.457~463 (2004)
- Fuks F, "DNA methylation and histone modification: teaming up to silence genes", Curr Opin Genet Dev, 15, pp.490~495 (2005)
- Klose RJ, "Genomic DNA methylation: the mark and its mediators", Trends Biochem Sci, 31, pp.89~97 (2006)
- Turner BM, "Histone acetylation and control of gene expression", J Cell Sci, 99, pp.13~20 (1991)
- Butler LM, "Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo", Cancer Res, 60, pp.5165~5170 (2000)
- Ishihama K, "Expression of HDAC1 and CBP", p300 in human colorectal carcinomas, 2007, pp.60, 1205~1210
- Maeda T, "Up-regulation of costimulatory", adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells, 2000, pp.96, 3847~3856
- Sasaki H, "Histone deacetylase I mRNA expression in lung cancer", Lung Cancer, 46, pp.171~178 (2004)
- Suzuki T, "Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines", Int J Cancer, 88, pp.992~997 (2000)
- Vigushin DM, "Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo", Clin Cancer Res, 7, pp.971~976 (2001)
- Chu DC, "The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma", J Urol, 167, pp.1854~1858 (2002)
- Young-Seoub Hong, "Hypermethylation of p16 INK4a in Korean Non-small Cell Lung CancerPatients", Journal of Korean Medical Science, 22(S), pp.32~37 (2007), 대한의학회
- Travis WD, "World Health Organization International Histological Classification of Tumours. Pathology and genetics of tumors of the lung, pleura, thymus and heart" (2004), IARC Press
- Mountain CF, "Revisions in the international staging for lung cancer", Chest, 111, pp.1711~1717 (1997)
- Kim DH, "p16INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer", Cancer Res, 61, pp.3419~3424 (2001)
- Lee YW, "Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens", Mol Cell Biol, 15, pp.2547~2557 (1995)
- Nakata S, "The methylation status and protein expression of CDH1, p16INK4A, and fragile histidine triad in nonsmall cell lung carcinoma", 106, pp.2190~2199 (2006)
- Swafford DS, "Frequent aberrant methylation of p16INK4A in primary rat lung tumors", Mol Cell Biol, 17, pp.1366~1374 (1997)
- Garder AF, "Molecular detection of early lung cancer", J Natl Cancer Inst, 91, pp.299~301 (1999)
- Jones PL, "Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription", Nature Genet, 19, pp.187~191 (1998)
- Nan X, "Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex", Nature, 393, pp.386~389 (1998)
- Cantor JP, "Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity", Int J Cancer, 120, pp.24~31 (2006)